415 related articles for article (PubMed ID: 25015995)
1. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model.
Liu Y; Fang X; Yuan J; Sun Z; Li C; Li R; Li L; Zhu C; Wan R; Guo R; Jin L; Li S
Endocr Relat Cancer; 2014 Aug; 21(4):639-51. PubMed ID: 25015995
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-Releasing Hormone Receptor Alters the Tumor Development and Growth in
Lee Y; Ma EL; Patel M; Kim G; Howe C; Pothoulakis C; Kim YS; Im E; Rhee SH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494263
[TBL] [Abstract][Full Text] [Related]
3. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
6. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
7. CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.
Fang X; Hong Y; Dai L; Qian Y; Zhu C; Wu B; Li S
Mol Carcinog; 2017 Nov; 56(11):2434-2445. PubMed ID: 28618089
[TBL] [Abstract][Full Text] [Related]
8. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
[TBL] [Abstract][Full Text] [Related]
9. Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization.
Chen H; Shi H; Liu Y; Ren X; He S; Chang X; Yin Y
Mol Med Rep; 2018 Jan; 17(1):234-242. PubMed ID: 29115460
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.
Huo X; Liu D; Gao L; Li L; Cao L
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.
Im E; Rhee SH; Park YS; Fiocchi C; Taché Y; Pothoulakis C
Gastroenterology; 2010 Jun; 138(7):2457-67, 2467.e1-5. PubMed ID: 20206175
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
[TBL] [Abstract][Full Text] [Related]
13. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
14. Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon Cancer.
Leon-Cabrera SA; Molina-Guzman E; Delgado-Ramirez YG; Vázquez-Sandoval A; Ledesma-Soto Y; Pérez-Plasencia CG; Chirino YI; Delgado-Buenrostro NL; Rodríguez-Sosa M; Vaca-Paniagua F; Ávila-Moreno F; Gutierrez-Cirlos EB; Arias-Romero LE; Terrazas LI
Cancer Immunol Res; 2017 May; 5(5):385-396. PubMed ID: 28385737
[TBL] [Abstract][Full Text] [Related]
15. [Changes of expression of miR-155 in colitis-associated colonic carcinogenesis].
Li W; Han W; Zhao X; Wang H
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):257-62. PubMed ID: 24989910
[TBL] [Abstract][Full Text] [Related]
16. Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Hahm KB
Int J Cancer; 2016 Mar; 138(6):1482-93. PubMed ID: 26476372
[TBL] [Abstract][Full Text] [Related]
17. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
18. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
[TBL] [Abstract][Full Text] [Related]
19. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
Dai Y; Jiao H; Teng G; Wang W; Zhang R; Wang Y; Hebbard L; George J; Qiao L
Mol Cancer Ther; 2014 May; 13(5):1206-16. PubMed ID: 24651526
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.
Osman J; Savari S; Chandrashekar NK; Bellamkonda K; Douglas D; Sjölander A
Oncotarget; 2017 May; 8(21):34773-34786. PubMed ID: 28410235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
